Highlights of the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)

The 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO), held on May 30-June 3 in Chicago, provided a window on the hive of activity that is current cancer therapy research. Presentations covered clinical studies of newer compounds; known compounds progressing to more advanced phases; known compounds under study for new indications; first-line treatments; treatments for refractory disease; agents under development as monotherapy, combination therapy or both; products for newly developed and recurrent disease; treatments for various cancer types, both metastatic and localized; in sum, research into practically every area of cancer treatment. An idea of the reach of the congress is provided by the selection of studies detailed below.